Tata India Pharma & Healthcare Fund - Direct Plan
Value Research Rating
Our Opinion
Riskometer
Very High
₹37.1854
As on 22-May-2026
Returns
Risk
This fund has Very High risk.
As per SEBI's Riskometer.
Portfolio of Tata India Pharma & Healthcare Fund - Direct Plan
Asset Allocation
Split between different types of investments
Market Cap Weightage
Split between categories of Equity investments
Peer Comparison
|
Fund name
|
Rating |
Our Opinion |
Risk
|
Return (%) |
|
Expense Ratio (%)
|
|---|---|---|---|---|---|---|
|
Tata India Pharma & Healthcare Fund - Direct Plan
|
|
|
Very High
|
loading... |
0.83 |
|
 |
|
Very High
|
loading... |
1.62 |
||
|
|
Very High
|
loading... |
0.92 |
||
 |
|
Very High
|
loading... |
1.36 |
||
|
|
Very High
|
loading... |
1.48 |
Other details of Tata India Pharma & Healthcare Fund - Direct Plan
Assets
₹1,325 Cr
Exit Load (Days)
0.25 (30)
Min. Investment (₹)
5,000
Min. Withdrawal (₹)
500
Min. SIP Investment (₹)
100
Min. No of Cheques
6
About Tata India Pharma & Healthcare Fund - Direct Plan
Tata India Pharma & Healthcare Fund - Direct Plan is a equity mutual fund scheme of Tata Mutual Fund. Launched on December 28, 2015, it is currently managed by Rajat Srivastava. The fund has an expense ratio of 0.83% with an overall AUM (Assets Under Management) of ₹1,325 Cr.
Tata India Pharma & Healthcare Fund - Direct Plan is mandated to invest at least 80 per cent of its assets in the shares of pharmaceutical and healthcare companies. The fund allows minimum lumpsum investment of ₹1,000 and minimum SIP of ₹100.
Investment Strategy
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Suitability
Nobody should invest in Pharma funds in our opinion, because:
- They have a narrow focus on only pharmaceutical and healthcare companies
- Instead, diversified equity funds which invest across sectors are better
If you still choose to invest:
- Invest only through SIP
- Have a 7+ year investment horizon
- Be prepared to withstand interim sharp declines in investment value
Capital Gains Taxation
- If the mutual fund units are sold after 1 year from the date of investment, gains upto Rs 1.25 lakh in a financial year are exempt from tax. Gains over Rs 1.25 lakh are taxed at the rate of 12.5%.
- If the mutual fund units are sold within 1 year from the date of investment, entire amount of gain is taxed at the rate of 20%.
- No tax is to be paid as long as you continue to hold the units.
Disclaimer: The tax information has been prepared on a best-effort basis using information available in the public domain and other sources that Value Research considers reliable. This is not meant as tax advice, and we advise you to consult your tax advisor before making any decision. Value Research takes no responsibility and assumes no liability for any loss or damage arising from any investment or redemption decision based on this information.
Dividend Taxation
- Dividends are added to the income of the investors and taxed according to their respective tax slabs. Further, if an investor's dividend income exceeds Rs. 10,000 in a financial year, the fund house also deducts a TDS of 10% before distributing the dividend.
Latest news on Tata India Pharma & Healthcare Fund - Direct Plan
FAQ for Tata India Pharma & Healthcare Fund - Direct Plan
How to Invest in Tata India Pharma & Healthcare Fund - Direct Plan?
Subscribers of Value Research Fund Advisor can conveniently invest in the low-cost direct plan of Tata India Pharma & Healthcare Fund - Direct Plan through the Value Research Fund Advisor website.
Alternatively, mutual funds can also be purchased directly from the respective fund house’s website. For example, Tata India Pharma & Healthcare Fund - Direct Plan can be bought from the Tata Mutual Fund website. In such a case, if you are investing in multiple funds from different fund houses, you will need to transact separately on each fund house’s website.
The third option is to invest offline, by seeking assistance from a mutual fund distributor. Most banks also act as mutual fund distributors, and you can approach your bank for help in completing your investment.
What is the current NAV of Tata India Pharma & Healthcare Fund - Direct Plan Today?
The latest declared NAV of Tata India Pharma & Healthcare Fund - Direct Plan, is ₹37.1854 as of 23-May-2026.
What are the top holdings of Tata India Pharma & Healthcare Fund - Direct Plan?
| Company | Percentage of Portfolio |
|---|---|
|
9.87
|
|
|
5.92
|
|
|
5.45
|
|
|
5.37
|
|
|
5.17
|
What is the return of Tata India Pharma & Healthcare Fund - Direct Plan in the last 5 years?
Over the past five years, Tata India Pharma & Healthcare Fund - Direct Plan has delivered an annualised return of 15.65% as of 23-May-2026.
What is the minimum investment required in Tata India Pharma & Healthcare Fund - Direct Plan?
The minimum investment required to start investing in Tata India Pharma & Healthcare Fund - Direct Plan is ₹5,000 for the lump sum option and ₹100 for the SIP (Systematic Investment Plan) option.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.